The Company is a Korea-based company mainly engaged in the production and sale of pharmaceuticals. The Company operates its business through three segments. Bio-Phamaceutical segment is involved in the manufacturing and sale of the main ingredients of finished pharmaceuticals such as antibiotics and immunosuppressants. Deoxyribonucleic Acid (DNA) Ribonucleic Acid (RNA) Synthesis segment is involved in the manufacturing and sale of materials for biotechnology research including gene manipulation, polymerase chain reaction (PCR), cloning, and sequencing. Genome Analysis Service segment is involved in the analysis of the gene sequences of the samples requested by customers and the provision of analysis results. The Company was founded on July 08, 1997 and its shares are listed on KOREA NEW EXCHANGE(KONEX) on July 18, 2016.
Headquarters
26-69,Gajeongbuk-Ro, Yuseong-Gu, Daejeon,Repubic Of Korea305-343
Daejeon; Daejeon;
Contact Details: Purchase the Genotech Corporation report to view the information.
Website: http://www.genotech.co.kr
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service